S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

ATOS Atossa Therapeutics Inc

1.41

-0.01 (-0.70%)

Last Updated: 12:08:36

Delayed by 15 minutes

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Atossa Therapeutics (NASDAQ:ATOS)
Historical Stock Chart
From Oct 2024 to Nov 2024

Click Here for more Atossa Therapeutics Charts.

Atossa Therapeutics (NASDAQ:ATOS)
Historical Stock Chart
From Nov 2023 to Nov 2024

Click Here for more Atossa Therapeutics Charts.

Atossa Therapeutics Inc News

Form 8-K - Current report
Monday 4 November 2024 (7 hours ago) • Edgar (US Regulatory)

Atossa Therapeutics Reports Positive KARISMA-Endoxifen Trial Results:
Monday 4 November 2024 (7 hours ago) • GlobeNewswire Inc.

Atossa Therapeutics Releases Promising Preliminary Analysis Demonstrating (Z)-Endoxifen’s Potential to Rapidly Reduce Ki-67 and Tumor Volume in ER+/HER2- Breast Cancer
Thursday 31 October 2024 (4 days ago) • GlobeNewswire Inc.

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Tuesday 22 October 2024 (2 weeks ago) • Edgar (US Regulatory)

Atossa Therapeutics to Participate in Fireside Chat with Karolinska Institute at BIO-EUROPE 2024 to Discuss a Unique Swedish American Collaboration to Prevent Breast Cancer
Monday 21 October 2024 (2 weeks ago) • GlobeNewswire Inc.

Atossa Therapeutics to Present at the 2024 Maxim Healthcare Virtual Summit
Monday 14 October 2024 (3 weeks ago) • GlobeNewswire Inc.

Atossa Therapeutics Commemorates Breast Cancer Awareness Month, Highlighting the Need for Innovation Across the Breast Cancer Treatment Continuum
Tuesday 1 October 2024 (1 month ago) • GlobeNewswire Inc.

Atossa Therapeutics Announces Support of Final Rule from FDA Requiring Patient Notification of Breast Density, a Critical Step in Addressing a Known Risk Factor for Breast Cancer
Tuesday 10 September 2024 (2 months ago) • GlobeNewswire Inc.

Atossa Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference
Tuesday 3 September 2024 (2 months ago) • GlobeNewswire Inc.

Atossa Therapeutics Granted Additional Patent Protection for Endoxifen
Wednesday 28 August 2024 (2 months ago) • GlobeNewswire Inc.

Atossa Therapeutics and Quantum Leap Healthcare Collaborative Dose First Patient in I-SPY 2 Trial Combining (Z)-Endoxifen with Abemaciclib for ER+/HER2- Breast Cancer
Wednesday 21 August 2024 (2 months ago) • GlobeNewswire Inc.

Atossa Therapeutics Announces the Appointment of Michael Parks as Vice President, Investor and Public Relations
Tuesday 20 August 2024 (3 months ago) • GlobeNewswire Inc.

More Atossa Therapeutics Inc News Articles

Accredited Solutions (PK)

Brookmount Explorations (PK)

Kraig Biocraft Laborator... (QB)

Decentral Life (PK)

Enzolytics (PK)

NioCorp Developments

Clean Vision (QB)

Valiant Eagle (PK)

FuelCell Energy

Northwest Biotherapeutics (QB)

Lightwave Logic

AMC Entertainment

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions